rnai and its applications

1
Exportin 5 pre-miRNA Injection ? Dicer-mediated cleavage siRNA-mediated changes in chromatin structure siRNA- mediated cleavage miRNA- mediated cleavage miRNA-mediated translation prevention Strand selection Nucleus Cytoplasm AAA AAA Helicase dsRNA-binding protein Dicer AAA AAA P body RNA degradation PAZ RNaseIII domain Argonaute Cap AAA HP1 H3 m HMT HP1 H3 m HMT HP1 H3 m HMT OH 3OH 3OH 3OH 33HO 3HO 3HO 3HO 3HO 3HO 3HO 3HO 3HO 3HO 3HO siRNA miRNA pri-miRNA AAA Drosha Pasha Cap RNAi and its applications René Ketting and Ronald Plasterk Double-stranded RNA (dsRNA) molecules can be used to induce a potent silencing process, known as RNA interference (RNAi). Key players in this process are two enzymes, Dicer and Argonaute, and a small RNA species, small interfering RNA (siRNA). The siRNA is made by the Dicer enzyme from a longer dsRNA substrate. One of the strands of the duplex siRNA then enters the RNA-induced silencing complex (RISC), a multi-protein complex that contains an Argonaute protein through which siRNAs induce their silencing effect. Because RNAi is both robust and specific it has become an important tool for gene knockdown experiments in the laboratory, and is being developed for use in agriculture and in the clinic. The central component of the RISC complex is a member of the Argonaute family. This protein interacts with Dicer and several other proteins, among which are dsRNA- binding proteins and RNA helicases. One of the two strands of the siRNA duplex, the one with the weakest 5end base pairing in the duplex, is selected to enter the RISC complex (this step is called strand selection). The Argonaute protein then binds the siRNA and recruits an homologous mRNA, after which it induces mRNA breakdown by introducing a nick into the mRNA. This cleavage reaction is carried out by the Piwi domain that folds into an RNaseH-like structure. The position of the nick is always halfway along the siRNA–mRNA duplex, opposite the phosphodiester bond between nucleotides 10 and 11 of the siRNA. In addition to mRNA breakdown, siRNAs can affect the chromatin structure of targeted genes, resulting in transcriptional inhibition. This phenomenon is mediated by another complex known as RITS (RNA-induced transcriptional silencing). siRNAs are thought to guide chromatin modifying enzymes (e.g. histone methyltransferases; HMTs) to specific DNA sequences, resulting in a silent chromatin structure (e.g. in methylated (m) histone H3 on lysine 9). Shortly after the discovery of RNAi, it became clear that this pathway was used in the cell by a large family of cell-autonomous short RNA — microRNAs (miRNAs). The precursors of these miRNAs, the primary miRNAs (pri-miRNAs), are made in the nucleus where they are processed by Drosha into pre-miRNAs. Similar to siRNAs, pre-miRNAs are then processed by Dicer in the cytoplasm, after which they also are bound by an Argonaute protein. miRNAs can induce silencing through mRNA cleavage, mainly in plants, or inhibition of translation, mainly in animals. The miRNA–RISC complex will specify cleavage if the mRNA has sufficient complementarity to the miRNA; if the mRNA does not have sufficient complementarity to be cleaved, the miRNA–RISC complex will repress mRNA translation. mRNAs that are silenced by miRNAs are recruited to so-called processing bodies (P bodies) where they are either stored or degraded. References Fire, A. et al. Nature 391, 806–811 (1998) | Ma, J.-B., Ye, K. & Patel, D. J. Nature 429, 318–322 (2004) | Matzke M. A. & Birchler J. A. Nature Rev. Genet. 6, 24–35 (2005) | McCaffrey, A. P. et al. Nature 418, 38–39 (2002) | Song, J.-J. et al. Science 305, 1434–1437 (2004) | Yuan, Y.-R. et al. Mol. Cell 19, 405–419 (2005) | Zhang, H. et al. Cell 118, 57–68 (2004) René Ketting and Ronald Plasterk are at the Hubrecht Laboratory, Uppsalalaan 8, 3584 CT Utrecht, The Netherlands. Image of RNaseIII structure courtesy of Lukasz Jaskiewicz and Witold Filipowicz, FMI, Basel, Switzerland. Image of Argonaute structure courtesy of Yu-Ren Yuan and Dinshaw Patel, MSKCC, New York, USA. Designed by Charlotte Cartwright and Simon Fenwick. Edited by Magdalena Skipper. © 2005 Nature Publishing Group. http://www.nature.com/reviews/genetics Sigma-Aldrich http://www.sigmaaldrich.com Your Source for RNA Interference Solutions Over the course of a few short years RNA Interference has grown from an interesting observation to an essential research tool in both industry and academia. The mission of Sigma-Aldrich is to make this tool available to researchers worldwide. Whether you choose to perform your experiments using synthetic RNA or vector based shRNA we have the solution for your needs. MISSION™ shRNA Libraries: As a sponsoring member of The RNAi Consortium (TRC) Sigma-Aldrich produces and distributes the lentivirus-based MISSION™ TRC shRNA Libraries consisting of 15,000 human gene targets (MISSION TRC-Hs1.0) and 15,000 mouse gene targets (MISSION TRC-Mm1.0). This renewable lentiviral system allows transduction of primary and non-dividing cells, as well as providing the ability to perform transient or stable silencing. The libraries are available in multiple formats — bacterial glycerol stocks, purified plasmid DNA, and lentiviral particles. Custom siRNA: Sigma-Proligo provides ready-to-use, high quality, desalted and purified custom siRNA. Our capacity ranges from microgram to multi-gram in either single strand or duplex siRNA and includes a broad range of modifications. Rapid turn around time is achieved with our high-throughput capability. We are fully licensed and offer competitive pricing. The means of introduction • Injection of in vitro synthesized dsRNA • Soaking in dsRNA • Feeding dsRNA-producing bacteria • Transfection of synthetic siRNA • Transgenes that produce dsRNA molecules (hairpins) • Viruses producing dsRNA molecules Rules of the game • Strand selection: the strand with the most loosely base-paired 5end in the siRNA duplex will enter the RISC complex • The 5end has to be phosphorylated • siRNAs need to have a 2-nucleotide 3overhang, which is recognized by the PAZ domain, present in Dicer and Argonaute proteins • The seed sequence of miRNA (nucleotides 2–7) requires perfect base pairing with target to induce silencing Genome-wide RNAi Libraries have been made that are used to silence genes in a genome- wide approach for several organisms. These libraries are now used for gene discovery as a rapid alternative to classic genetic approaches. Most methods deliver long dsRNA molecules, resulting in gene silencing by a pool of siRNAs. Exceptions to this are the viruses that are used in humans and mice: in these cases siRNAs of only one type are being produced, derived either from custom-made short RNA hairpins or hairpins that are built into larger primary miRNA transcripts. Injection Soaking Feeding Virus Caenorhabditis elegans + + + Drosophila melanogaster + Nicotiana benthamiana + Planaria + Mouse + Human + Therapy and crop improvement The specificity and robustness of RNAi have triggered an immense interest in using RNAi as a tool in various settings. For example, RNAi is used to improve crops by providing resistance against parasites, and modified versions of siRNAs that are directed against disease-causing genes are being developed. Some of these therapeutic siRNAs are already being tested in clinical trials. The principle of in vivo RNAi is indicated in the figure, where luciferase in the liver is specifically silenced by siRNAs. Reporter + anti-luciferase siRNA Luciferase reporter High intensity Low intensity

Upload: others

Post on 03-Feb-2022

5 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: RNAi and its applications

Exportin 5

pre-miRNA

Injection

?

Dicer-mediated cleavage

siRNA-mediated changes in chromatin structure

siRNA-mediated cleavage

miRNA-mediated cleavage

miRNA-mediatedtranslation prevention

Strand selection

Nucleus

Cytoplasm

AAA

AAA

Helicase

dsRNA-binding protein

Dicer

AAA

AAA

P body

RNAdegradation

PAZ RNaseIIIdomain

Argonaute

Cap

AAA

HP1H3

mHMT

HP1H3

mHMT

HP1H3

mHMT

OH 3′

OH 3′

OH 3′

OH 3′3′ HO 3′ HO

3′ HO

3′ HO

3′ HO

3′ HO

3′ HO

3′ HO 3′ HO

3′ HO

3′ HO

siRNA miRNA

pri-miRNA

AAADrosha

PashaCap

RNAi and its applicationsRené Ketting and Ronald Plasterk

Double-stranded RNA (dsRNA) molecules can be used to induce a potent silencing process, known as RNA interference (RNAi). Key players in this process are two enzymes, Dicer and Argonaute, and a small RNA species, small interfering RNA (siRNA). The siRNA is made by the Dicer enzyme from a longer dsRNA substrate. One of the strands of the duplex siRNA then

enters the RNA-induced silencing complex (RISC), a multi-protein complex that contains an Argonaute protein through which siRNAs induce their silencing effect. Because RNAi is both robust and specific it has become an important tool for gene knockdown experiments in the laboratory, and is being developed for use in agriculture and in the clinic.

The central component of the RISC complex is a member of the Argonaute family. This protein interacts with Dicer and several other proteins, among which are dsRNA-binding proteins and RNA helicases. One of the two strands of the siRNA duplex, the one with the weakest 5′ end base pairing in the duplex, is selected to enter the RISC complex (this step is called strand selection). The Argonaute protein then binds the siRNA and recruits an homologous mRNA, after which it induces mRNA breakdown by introducing a nick into the mRNA. This cleavage reaction is carried out by the Piwi domain that folds into an RNaseH-like structure. The position of the nick is always halfway along the siRNA–mRNA duplex, opposite the phosphodiester bond between nucleotides 10 and 11 of the siRNA.

In addition to mRNA breakdown, siRNAs can affect the chromatin structure of targeted genes, resulting in transcriptional inhibition. This phenomenon is mediated by another complex known as RITS (RNA-induced transcriptional silencing). siRNAs are thought to guide chromatin modifying enzymes (e.g. histone methyltransferases; HMTs) to specific DNA sequences, resulting in a silent chromatin structure (e.g. in methylated (m) histone H3 on lysine 9).

Shortly after the discovery of RNAi, it became clear that this pathway was used in the cell by a large family of cell-autonomous short RNA — microRNAs (miRNAs). The precursors of these miRNAs, the primary miRNAs (pri-miRNAs), are made in the nucleus where they are processed by Drosha into pre-miRNAs. Similar to siRNAs, pre-miRNAs are then processed by Dicer in the cytoplasm, after which they also are bound by an Argonaute protein. miRNAs can induce silencing through mRNA cleavage, mainly in plants, or inhibition of translation, mainly in animals. The miRNA–RISC complex will specify cleavage if the mRNA has sufficient complementarity to the miRNA; if the mRNA does not have sufficient complementarity to be cleaved, the miRNA–RISC complex will repress mRNA translation. mRNAs that are silenced by miRNAs are recruited to so-called processing bodies (P bodies) where they are either stored or degraded.

ReferencesFire, A. et al. Nature 391, 806–811 (1998) | Ma, J.-B., Ye, K. & Patel, D. J. Nature 429, 318–322 (2004) | Matzke M. A. & Birchler J. A. Nature Rev. Genet. 6, 24–35 (2005) | McCaffrey, A. P. et al. Nature 418, 38–39 (2002) | Song, J.-J. et al. Science 305, 1434–1437 (2004) | Yuan, Y.-R. et al. Mol. Cell 19, 405–419 (2005) | Zhang, H. et al. Cell 118, 57–68 (2004)

René Ketting and Ronald Plasterk are at the Hubrecht Laboratory, Uppsalalaan 8, 3584 CT Utrecht, The Netherlands. Image of RNaseIII structure courtesy of Lukasz Jaskiewicz and Witold Filipowicz, FMI, Basel, Switzerland. Image of Argonaute structure courtesy of Yu-Ren Yuan and Dinshaw Patel, MSKCC, New York, USA. Designed by Charlotte Cartwright and Simon Fenwick. Edited by Magdalena Skipper. © 2005 Nature Publishing Group. http://www.nature.com/reviews/genetics

Sigma-Aldrich http://www.sigmaaldrich.com

Your Source for RNA Interference Solutions

Over the course of a few short years RNA Interference has grown from an interesting observation to an essential research tool in both industry and academia. The mission of Sigma-Aldrich is to make this tool available to researchers worldwide. Whether you choose to perform your experiments using synthetic RNA or vector based shRNA we have the solution for your needs.

MISSION™ shRNA Libraries: As a sponsoring member of The RNAi Consortium (TRC) Sigma-Aldrich produces and distributes the lentivirus-based MISSION™ TRC shRNA Libraries consisting of 15,000 human gene targets (MISSION TRC-Hs1.0) and 15,000 mouse gene targets (MISSION TRC-Mm1.0). This renewable lentiviral system allows transduction of primary and non-dividing cells, as well as providing the ability to perform transient or stable silencing. The libraries are available in multiple formats — bacterial glycerol stocks, purified plasmid DNA, and lentiviral particles.

Custom siRNA: Sigma-Proligo provides ready-to-use, high quality, desalted and purified custom siRNA. Our capacity ranges from microgram to multi-gram in either single strand or duplex siRNA and includes a broad range of modifications. Rapid turn around time is achieved with our high-throughput capability. We are fully licensed and offer competitive pricing.

The means of introduction• Injection of in vitro synthesized dsRNA

• Soaking in dsRNA

• Feeding dsRNA-producing bacteria

• Transfection of synthetic siRNA

• Transgenes that produce dsRNA molecules (hairpins)

• Viruses producing dsRNA molecules

Rules of the game• Strand selection: the strand with the most loosely base-paired

5′ end in the siRNA duplex will enter the RISC complex

• The 5′ end has to be phosphorylated

• siRNAs need to have a 2-nucleotide 3′ overhang, which is recognized by the PAZ domain, present in Dicer and Argonaute proteins

• The seed sequence of miRNA (nucleotides 2–7) requires perfect base pairing with target to induce silencing

Genome-wide RNAiLibraries have been made that are used to silence genes in a genome-wide approach for several organisms. These libraries are now used for gene discovery as a rapid alternative to classic genetic approaches. Most methods deliver long dsRNA molecules, resulting in gene silencing by a pool of siRNAs. Exceptions to this are the viruses that are used in humans and mice: in these cases siRNAs of only one type are being produced, derived either from custom-made short RNA hairpins or hairpins that are built into larger primary miRNA transcripts.

Injection Soaking Feeding Virus

Caenorhabditis elegans + + +

Drosophila melanogaster +

Nicotiana benthamiana +

Planaria +

Mouse +

Human +

Therapy and crop improvementThe specificity and robustness of RNAi have triggered an immense interest in using RNAi as a tool in various settings. For example, RNAi is used to improve crops by providing resistance against parasites, and modified versions of siRNAs that are directed against disease-causing genes are being developed. Some of these therapeutic siRNAs are already being tested in clinical trials. The principle of in vivo RNAi is indicated in the figure, where luciferase in the liver is specifically silenced by siRNAs.

Reporter +anti-luciferase

siRNA

Luciferasereporter

Highintensity

Lowintensity

nrg1206-poster.indd 1 8/11/05 10:13:21 am